Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$30 Mln
Revenue (TTM)
$0 Mln
Net Profit (TTM)
$0 Mln
ROE
-0.9 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
0.5
Industry P/E
--
EV/EBITDA
-0.5
Div. Yield
0 %
Debt to Equity
0
Book Value
$--
EPS
$-0.8
Face value
--
Shares outstanding
90,377,000
CFO
$-859.84 Mln
EBITDA
$-1,104.26 Mln
Net Profit
$-1,079.82 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Allakos (ALLK)
| -72.7 | 3.0 | 5.5 | -72.3 | -53.3 | -65.3 | -- |
|
BSE Sensex*
| 4.0 | -1.1 | 8.1 | 5.3 | 16.6 | 18.9 | 11.6 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|
|
Allakos (ALLK)
| -55.4 | -67.6 | -14.0 | -93.0 | 46.8 | 82.4 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Allakos (ALLK)
|
0.3 | 29.7 | 0.0 | -70.9 | -- | -110.5 | -- | 0.5 |
| 50.1 | 8,093.9 | 1,208.8 | 131.7 | 13.4 | 6.3 | 61.9 | 4.0 | |
| 128.1 | 8,293.4 | 562.1 | -155.7 | -19.3 | -47.5 | -- | 24.2 | |
| 145.3 | 7,417.9 | 4,022.6 | -31.6 | 3.7 | -1.1 | -- | 2.3 | |
| 52.3 | 10,095.9 | 2,828.1 | -1,019.8 | -36.2 | -36.4 | -- | 4.2 | |
| 40.7 | 11,385.6 | 2,298.9 | 643.6 | 35.4 | 29.2 | 19 | 5.3 | |
| 302.7 | 8,650.6 | 2,156.6 | 416.4 | 21.2 | 56.5 | 23 | 14.4 | |
| 25.4 | 10,055.3 | 3,159.0 | -3,357.0 | -76.7 | -30.5 | -- | 1.0 | |
| 127.3 | 12,370.7 | 2,412.6 | 305.8 | 20.5 | 11.6 | 42.3 | 4.9 | |
| 291.7 | 13,016.0 | 2,994.1 | 1,210.7 | 51.4 | 18.8 | 11.5 | 1.9 |
As of May 15, 2025, operates as a subsidiary of Concentra Biosciences, LLC. Address: 825 Industrial Road, San Carlos, CA, United States, 94070
CEO & Director
Dr. Robert Alexander Ph.D.
CEO & Director
Dr. Robert Alexander Ph.D.
Headquarters
San Carlos, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Allakos Inc (ALLK) stood at $ 64 Mln as on 31-Mar-25
The share price of Allakos Inc (ALLK) is $0.33 (NASDAQ) as of 15-May-2025 09:30 EDT. Allakos Inc (ALLK) has given a return of -53.3% in the last 3 years.
Allakos Inc (ALLK) has a market capitalisation of $ 30 Mln as on 15-May-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Allakos Inc (ALLK) is 0.54 times as on 15-May-2025, a 80% discount to its peers’ median range of 2.75 times.
Since, TTM earnings of Allakos Inc (ALLK) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Allakos Inc (ALLK) and enter the required number of quantities and click on buy to purchase the shares of Allakos Inc (ALLK).
As of May 15, 2025, operates as a subsidiary of Concentra Biosciences, LLC. Address: 825 Industrial Road, San Carlos, CA, United States, 94070
The CEO & director of Dr. Robert Alexander Ph.D.. is Allakos Inc (ALLK), and CFO & Sr. VP is Dr. Robert Alexander Ph.D..
There is no promoter pledging in Allakos Inc (ALLK).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,247
|
|
|
1,229
|
|
|
1,130
|
|
|
1,073
|
|
|
1,050
|
|
|
869
|
|
|
827
|
|
|
808
|
|
|
742
|
| Allakos Inc. (ALLK) | Ratios |
|---|---|
|
Return on equity(%)
|
-110.53
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
--
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Allakos Inc (ALLK) was $0 Mln.
$0.00
(
